Assay device for one step detection of analyte

• US 5,686,315 A
• Filed: 01/21/1994
• Issued: 11/11/1997
• Est. Priority Date: 06/14/1991
• Status: Expired due to Fees

• Current Assignee: Quidel Corporation
• Original Assignee: Quidel Corporation
• Inventors: Pawlak, Jan W., Sand, Theodore T., Bacquet, Cathy A., Pronovost, Allan D.
• Primary Examiner(s): Spiegel, Carol A.
• Application Number:
  US08/184,354
• Time in Patent Office: 1,390 Days
• Field of Search: 422/55-60, 422/101, 435/5, 435/67.1, 435/7.92, 435/7.2, 435/805, 435/969, 435/970, 436/518, 436/523, 436/525, 436/527, 436/528, 436/531, 436/533, 436/534, 436/805, 436/810, 436/814, 436/818
• US Class Current: 436/510
• CPC Class Codes: G01N 33/54386 Analytical elements
• CPC Class Codes: G01N 33/585 with a particulate label, e.g. coloured latex
• CPC Class Codes: G01N 33/586 Liposomes, microcapsules or cells
• CPC Class Codes: G01N 33/76 Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
• CPC Class Codes: Y10S 435/969 Multiple layering of reactants
• CPC Class Codes: Y10S 435/97 Test strip or test slide
• CPC Class Codes: Y10S 436/805 Optical property
• CPC Class Codes: Y10S 436/81 Tube, bottle, or dipstick
• CPC Class Codes: Y10S 436/818 Human chorionic gonadotropin

Abstract

A "one step" device for the detection of analytein clinical assays is disclosed. A visible label comprising a visible moiety and a ligand that binds to or competes with analyte is contained in a fluid conducting membrane or prefilter; and the analyte and associated ligand are conducted by the flow of sample into a detection zone. The detection zone contains a capture reagent that binds to label or to analyte bound to label.

Claims

1. An assay device for one-step detection of the presence or absence of an analyte in a sample, wherein said device comprises:

a) a removable fluid-conducting membrane, to which the sample is applied, containing a mobilizable label, which label comprises a visible moiety coupled to a ligand which ligand specifically binds said analyte or competes with said analyte for a specific binding partner to the analyte, said membrane being in fluid communication with and on top of

b) a matrix containing a first detection zone wherein said detection zone contains immobilized thereon said specific binding partner to the analyte, said matrix being in fluid communication with and on top of

c) an absorbent capable of drawing liquids applied to said device through said membrane and said matrix.

2. The device of claim 1 wherein the ligand is a specific binding partner of the analyte.

3. The device of claim 2 wherein the ligand is an antibody or immunologically reactive fragment thereof.

4. The device of claim 1 wherein the ligand is a competitor with the analyte.

5. The device of claim 1 wherein the ligand is additional analyte that competes with said analyte in said detection zone.

6. The device of claim 1 wherein the specific binding partner to the analyte is an antibody or immunologically reactive fragment thereof.

7. The device of claim 1 wherein said visible moiety is a colored latex bead.

8. The device of claim 1 wherein said visible moiety is a liposome containing dye.

9. The device of claim 1 wherein said matrix further contains a second detection zone in the form of a spatially distinct positive control zone underneath the removable fluid conducting membrane comprising an immobilized detection reagent to act as a positive control which is capable of binding said label in the absence of said analyte.

10. The device of claim 9 wherein said second detection zone contains an immobilized specific binding partner for said ligand.

11. The device of claim 1, wherein said detection zone further contains immobilized thereon a control binding partner and wherein said fluid-conducting membrane further comprises a mobilizable control visible moiety that does not contain said ligand and is coupled to a control reagent that is capable of being captured by said control binding partner in said detection zone.

12. The device of claim 11, wherein said control visible moiety is coupled to said ligand in part a) of claim 1.

13. A method to detect the presence or absence of said analyte in a sample, which method comprises contacting the fluid-conducting membrane of the assay device of claim 1 with the sample so that the sample passes through the fluid-conducting membrane as defined in part a), mobilizing the label, and through the matrix of part b) and into the absorbent of part c);

removing the membrane; and

observing the binding of the label in said first detection zone as a function of the presence or absence of analyte.

14. The method of claim 13 wherein said analyte is human chorionic gonadotropin (hCG).

15. The method of claim 14 wherein the specific binding partner for analyte is a monoclonal antibody immunoreactive to hCG.